Genetic diversity and evolution of hepatitis C virus - 15 years on

被引:647
作者
Simmonds, P [1 ]
机构
[1] Univ Edinburgh, Ctr Infect Dis, Edinburgh EH9 1QH, Midlothian, Scotland
关键词
D O I
10.1099/vir.0.80401-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In the 15 years since the discovery of hepatitis C virus (HCV), much has been learned about its role as a major causative agent of human liver disease and its ability to persist in the face of host-cell defences and the immune system. This review describes what is known about the diversity of HCV, the current classification of HCV genotypes within the family Flaviviridae and how this genetic diversity contributes to its pathogenesis. On one hand, diversification of HCV has been constrained by its intimate adaptation to its host. Despite the > 30 % nucleotide sequence divergence between genotypes, HCV variants nevertheless remain remarkably similar in their transmission dynamics, persistence and disease development. Nowhere is this more evident than in the evolutionary conservation of numerous evasion methods to counteract the cell's innate antiviral defence pathways; this series of highly complex virus-host interactions may represent key components in establishing its 'ecological niche' in the human liver. On the other hand, the mutability and large population size of HCV enables it to respond very rapidly to new selection pressures, manifested by immune-driven changes in T- and B-cell epitopes that are encountered on transmission between individuals with different antigen-recognition repertoires. If human immunodeficiency virus type 1 is a precedent, future therapies that target virus protease or polymerase enzymes may also select very rapidly for antiviral-resistant mutants. These contrasting aspects of conservatism and adaptability provide a fascinating paradigm in which to explore the complex selection pressures that underlie the evolution of HCV and other persistent viruses.
引用
收藏
页码:3173 / 3188
页数:16
相关论文
共 151 条
[101]   The nonstructural NS5A protein of hepatitis C virus: An expanding, multifunctional role in enhancing hepatitis C virus pathogenesis [J].
Reyes, GR .
JOURNAL OF BIOMEDICAL SCIENCE, 2002, 9 (03) :187-197
[102]   Immunogenicity of variable regions of hepatitis C virus proteins:: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA [J].
Rodríguez-López, M ;
Riezu-Boj, JI ;
Ruiz, M ;
Berasain, C ;
Civeira, MP ;
Prieto, J ;
Borrás-Cuesta, F .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :727-738
[103]   Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 [J].
Rubbia-Brandt, L ;
Quadri, R ;
Abid, K ;
Giostra, E ;
Malé, PJ ;
Mentha, G ;
Spahr, L ;
Zarski, JP ;
Borisch, B ;
Hadengue, A ;
Negro, F .
JOURNAL OF HEPATOLOGY, 2000, 33 (01) :106-115
[104]   Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry) [J].
Ruggieri, A ;
Argentini, C ;
Kouruma, F ;
Chionne, P ;
DUgo, E ;
Spada, E ;
Dettori, S ;
Sabbatani, S ;
Rapicetta, M .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :2073-2076
[105]  
Saito T, 2003, AM J GASTROENTEROL, V98, P1377, DOI [10.1016/S0002-9270(03)00243-0, 10.1111/j.1572-0241.2003.07469.x]
[106]   Evidence of recombination among enteroviruses [J].
Santti, J ;
Hyypiä, T ;
Kinnunen, L ;
Salminen, M .
JOURNAL OF VIROLOGY, 1999, 73 (10) :8741-8749
[107]   Non-nucleoside inhibitors of the HCV polymerase [J].
Sarisky, RT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) :14-16
[108]   Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses [J].
Sarrazin, C ;
Herrmann, E ;
Bruch, K ;
Zeuzem, S .
JOURNAL OF VIROLOGY, 2002, 76 (21) :11079-11090
[109]   The dsRNA binding protein family: critical roles, diverse cellular functions [J].
Saunders, LR ;
Barber, GN .
FASEB JOURNAL, 2003, 17 (09) :961-983
[110]   Natural history of chronic hepatitis C [J].
Seeff, LB .
HEPATOLOGY, 2002, 36 (05) :S35-S46